Tadeusz Kubicki
6PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jul 16, 2025
Evolution of clonal hematopoiesis on and off lenalidomide maintenance for multiple myeloma.Jennifer H Cooperrider, Diren Arda Karaoglu, Tadeusz Kubicki
|Oct 07, 2024
Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP).Benjamin A Derman, Ajay Major, Jennifer Cooperrider
|May 29, 2024
Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant.Benjamin A Derman, Jennifer Cooperrider, Jacalyn Rosenblatt
|May 07, 2024
Mass spectrometry-based assessment of M protein in peripheral blood during maintenance therapy in multiple myeloma.Tadeusz Kubicki, Dominik Dytfeld, David Barnidge
|Sep 10, 2023
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial.Tadeusz Kubicki, Dominik Dytfeld, Tomasz Wróbel
|Feb 10, 2021
Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous stem cell transplantation.Benjamin A Derman, Andrew T Stefka, Ken Jiang
Pageof 1
Frequent Collaborators
4 joint publications
Benjamin A Derman
4 joint publications
Andrzej Jakubowiak
2 joint publications
Andrew T Stefka
2 joint publications
Łukasz Szukalski
2 joint publications
Krzysztof Jamroziak
2 joint publications
Paweł Robak
2 joint publications
Jan Maciej Zaucha
2 joint publications
Agata Tyczyńska
2 joint publications
Bartosz Puła
2 joint publications
Anna Łojko-Dankowska
